Therapeutic Antibodies – News and Features

News
Affitech to Play key Role in Major EU Embryonal Tumor Pipeline Project
Proprietary discovery platforms to be utilized to identify fully human therapeutic antibody candidates.

News
NIH Selects Regeneron for Knockout Mouse Project
Regeneron will use its VelociGene® technology to target 3,500 genes over five years, providing models of human diseases.

News
Dyax and Serono Announces Agreements for Discovery of Therapeutic Antibodies
Dyax will perform funded research on certain targets of Serono to identify therapeutic antibodies.

News
Research and Markets Announces Addition of the Fourth Wave: A new Generation of Protein-Based Therapeutics
Companies are developing technologies that will remodel recombinant protein and MAb therapeutics into next-generation drugs.

News
Medarex and GenPat77 Announce Therapeutic Antibody Co-Development Agreement
The companies plan to use Medarex's UltiMAb Human Antibody Development System® to generate antibodies to disease targets.

News
MorphoSys Obtains PER.C6® Human Cell Line from Crucell
The license agreement allows MorphoSys to use the PER.C6® cell line for production of antibody material in MOR103 program.

News
Analyze Americans' Attitudes toward Pharmacogenomics and Personalized Medicine
In this report, Research and Markets examine how the use of pharmacogenomics will affect today's drug development strategies.

News
YM Biosciences Licenses Monoclonal Antibody to Daiichi
Daiichi will develop nimotuzumab for the Japanese market in several cancer indications.

News
Lumera Invited to Demonstrate its ProteomicProcessor™ at Cold Spring Harbor Laboratory
Three week proteomics course to highlight Lumera's technology to leading academic and pharmaceutical researchers.

News
MorphoSys Announces Expansion of Collaboration with Novartis
The original therapeutic antibody collaboration agreement provided for a three-year term with an option for Novartis to extend. The collaboration will now go through May 2011.
Advertisement